Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 56,654 | 47,319 | 27,713 | 48,155 | 16,215 |
| Depreciation Amortization | 110,996 | 69,763 | 35,019 | 148,021 | 113,126 |
| Income taxes - deferred | -16,658 | -7,925 | -4,412 | -2,153 | -1,815 |
| Accounts receivable | -4,520 | -4,330 | 4,832 | 3,594 | 1,268 |
| Accounts payable and accrued liabilities | -12,088 | -6,144 | -2,536 | 5,061 | 106 |
| Other Working Capital | -71,787 | -7,833 | -5,616 | 21,731 | 23,833 |
| Other Operating Activity | 57,739 | 38,485 | 6,937 | 50,340 | 48,678 |
| Operating Cash Flow | $120,336 | $129,335 | $61,937 | $274,749 | $201,411 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 76,626 | 47,207 | 21,550 | 22,000 | 6,000 |
| PPE Investments | -1,082 | -838 | -568 | -461 | -297 |
| Net Acquisitions | -267,538 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -84,003 | -73,403 | -39,110 | -92,351 | -51,418 |
| Investing Cash Flow | $-275,997 | $-27,034 | $-18,128 | $-70,812 | $-45,715 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 313,175 | N/A | N/A | 235,220 | 235,220 |
| Debt Repayment | -124,912 | -124,885 | -45,833 | -301,138 | -255,305 |
| Common Stock Issued | 10,900 | 10,280 | 4,561 | 9,101 | 5,861 |
| Common Stock Repurchased | -35,000 | -35,000 | N/A | -75,000 | -50,000 |
| Other Financing Activity | -183,489 | -18,749 | -12,874 | -8,361 | -8,128 |
| Financing Cash Flow | $-19,326 | $-168,354 | $-54,146 | $-140,178 | $-72,352 |
| Beginning Cash Position | 239,994 | 239,994 | 239,994 | 176,235 | 176,235 |
| End Cash Position | 65,007 | 173,941 | 229,657 | 239,994 | 259,579 |
| Net Cash Flow | $-174,987 | $-66,053 | $-10,337 | $63,759 | $83,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | 120,336 | 129,335 | 61,937 | 274,749 | 201,411 |
| Capital Expenditure | -1,082 | -838 | -568 | -461 | -297 |
| Free Cash Flow | 119,254 | 128,497 | 61,369 | 274,288 | 201,114 |